Abstract

: Tuberculosis (TB) is one of the most widespread and lethal infectious diseases worldwide. The emergence of drug-resistant TB has hampered effective TB treatment and control. Prokaryotic ubiquitin-like Protein-Proteasome System (PPS) contributes to the survival of Mycobacterium tuberculosis in the host. However, whether PPS effects drug resistance of isoniazid mono-resistant Mycobacterium tuberculosis (INH-MTB) is still unknown. This study aimed at exploring the effect of PPS on drug resistance of INH-MTB strain. In this study, over-expression of strains and deletion of mutant strains were constructed using electroporation. The researchers identified these constructed strains by Quantitative Reverse Transcription Polymerase Chain Reaction (RT-qPCR) or PCR. The Minimum Inhibitory Concentration (MIC) of isoniazid in INH-MTB strain and its derivative PPS mutant strains were determined using the Resazurin micro-titre assay. The MIC of isoniazid was 8 µg/mL higher in INH-MTB with Pup over-expression strain than that in INH-MTB. The MIC of isoniazid was 4.82 µg/mL, 4.98 µg/mL, 4.99 µg/mL, and 4.9 µg/mL lower in INH-MTB with deletion of Pup, Dop, PafA or Mpa strains than that in INH-MTB, respectively. The differences had statistical significance (P 0.05). These results show that PPS effects the drug resistance of the INH-MTB strain.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call